According to the Government of Canada’s Preliminary guidance on key populations for early COVID-19 immunization, people with high-risk medical conditions are ranked immediately following healthcare workers. You can find the information here:

Provincial and territorial public health departments are ultimately by responsible for determining vaccination priority in their jurisdictions.

There are, however, some key questions that need to be answered. Will the vaccine be effective in patients with myeloma? Will it be safe? As such, we are eagerly awaiting guidance from the Canadian and International myeloma expert community (i.e., Canadian Myeloma Research Group; International Myeloma Working Group).

We could find links to every provincial/territorial website or find an article that summarizes it all.

For example:

• https://www.huffingtonpost.ca/entry/covid-vaccine-distribution-canada_ca_5fd0ce8fc5b66a7584111181 – but its not very detailed.
• https://www.ctvnews.ca/health/coronavirus/what-provinces-and-territories-have-said-about-covid-19-vaccine-plans-1.5219892